广州市艾滋病检测策略的卫生经济学评价
本文选题:艾滋病 切入点:检测 出处:《中国疾病预防控制中心》2013年博士论文 论文类型:学位论文
【摘要】:目的:对调查地区的艾滋病检扩大测策略进行卫生经济学评价,分析其成本-效果和成本效用,为卫生决策部门以后因地制宜的实施或调整该策略提供科学依据。 方法:本研究包括两个部分,第一部分是以现场调查为基础,旨在调查选定地区自2006年至2011年底HIV检测策略的实施情况,测算该地区的HIV扩大检测策略的逐年成本投入和总成本投入,收集该地区逐年的检测人次数、检测阳性数以及纳入管理的阳性人数;第二部分为利用Bernoulli-process模型计算因性传播途径所避免的新发感染人数以及因注射吸毒感染途径而避免的新发感染人数。此外,通过构建Markov模型模拟计算获得的质量调整生命年,利用上述数据对广州市2006-2011年HIV检测策略进行成本-效果分析和成本-效用分析。 结果:广州市2006-2011年HIV检测策略总的成本投入呈逐年上升趋势,总成本为14849.247万元;2006年总成本投入为1670.483万元,而2011年则上升为3845.237万元。 对广州市HIV检测策略进行成本-效果分析,以每新发现一例HIV阳性感染者作为效果指标,广州市2006-2011年的平均成本-效果比为1.380万元/每发现1例HIV感染者;以每将一例阳性病人进纳入到管理体系中作为效果指标,近6年的平均成本-效果比为1.612万元/每纳入1例HIV感染者;以每避免一例HIV阳性感染者作为效果指标,则近6年平均每避免一例新发感染需要花费约为12.703万元,波动范围为1.802万元-62.131万元;通过分析广州市接受HIV检测的人群中HIV血清阳性率与成本-效果比关系得出,随着HIV血清阳性率的降低,每发现一例HIV感染者的成本上升。 对广州市HIV检测策略进行成本-效用分析,结果发现:广州市HIV检测措施实施后,若不考虑对HIV感染者随访治疗等费用,则每挽救一个QALY需花费0.221万元;在考虑对HIV感染者/AIDS病人的随访治疗费用的前提下,每挽回一个QALY需要花费1.574万元。 结论:广州市HIV检测策略的实施是符合成本效益原则的,应在现有HIV检测策略实施的基础上,进一步扩大HIV检测覆盖面,并加强对重点人群的筛查,以发现更多潜在的HIV感染者。但研究仅调查了广州地区的数据,仍然缺乏不同流行水平和不同经济水平地区的相关证据。应根据HIV不同流行水平和当地不同的经济水平,开展HIV检查策略的卫生经济学评价。
[Abstract]:Objective: to evaluate the strategy of expanding HIV / AIDS testing in the investigation area, analyze its cost effect and cost utility, and provide a scientific basis for the implementation or adjustment of the strategy in accordance with the local conditions in the future. Methods: this study consists of two parts. The first part is based on the field investigation. The purpose of this study is to investigate the implementation of HIV detection strategy in selected areas from 2006 to end of 2011. The annual cost input and total cost input of the expanded HIV detection strategy in this area were calculated, and the number of person-times tested, the number of positive people tested and the number of positive people brought into the management were collected year by year in this area. The second part is to calculate the number of new infections avoided by the route of sexual transmission and the number of new infections avoided by the route of injecting drug use using the Bernoulli-process model. In addition, the quality-adjusted life years obtained by constructing the Markov model are simulated and calculated. The above data are used to analyze the cost-effect and cost-utility of HIV detection strategy in Guangzhou from 2006 to 2011. Results: from 2006 to 2011, the total cost of HIV detection strategy in Guangzhou increased year by year, with the total cost of one hundred and forty-eight million four hundred and ninety-two thousand and four hundred and seventy yuan, sixteen million seven hundred and four thousand and eight hundred and thirty yuan in 2006 and thirty-eight million four hundred and fifty-two thousand and three hundred and seventy yuan in 2011. The cost-effect analysis of HIV detection strategy in Guangzhou was carried out. The average cost-effect ratio between 2006 and 2011 was 13,800 yuan per case of HIV infection. Taking each positive patient into the management system as an effect indicator, the average cost-effect ratio of nearly 6 years was 16,120 yuan per case of HIV infection, and one case of HIV positive infection was avoided as an effect index. The average cost of avoiding a new infection in the past 6 years was about 127,030 yuan, with a fluctuation range of 18,020 yuan to 621,310 yuan. The relationship between the positive rate of HIV serum and the cost-effectiveness ratio among the people who were tested for HIV in Guangzhou City was analyzed. As the HIV seropositive rate decreases, the cost of each case of HIV infection increases. The cost-utility analysis of HIV detection strategy in Guangzhou was carried out. The results showed that if the cost of follow-up treatment for HIV infected persons was not considered, it would cost 2,210 yuan to save a QALY after the implementation of HIV detection measures in Guangzhou; After considering the cost of follow-up treatment for patients with HIV / AIDS, it costs $15,740 for each QALY to be recovered. Conclusion: the implementation of HIV detection strategy in Guangzhou is in line with the principle of cost-effectiveness. Based on the implementation of the existing HIV detection strategy, the coverage of HIV detection should be further expanded, and the screening of key population should be strengthened. In order to find more potential HIV infections, however, the study only investigated data from Guangzhou, and still lacked relevant evidence for different epidemic levels and different economic levels. Different HIV prevalence levels and different local economic levels should be taken into account. To evaluate the health economics of HIV inspection strategy.
【学位授予单位】:中国疾病预防控制中心
【学位级别】:博士
【学位授予年份】:2013
【分类号】:R512.91
【相似文献】
相关期刊论文 前10条
1 赵东阳,张根红,王宏;浅析卫生经济学评价方法[J];河南预防医学杂志;2005年04期
2 王剑;;我国健康教育的卫生经济学评价[J];健康教育与健康促进;2012年03期
3 杨国平;陈敏生;王煜非;祝延红;肖忠明;郎涛;傅蔷;李敏;夏葳;;公共实验平台的卫生经济学评价[J];中国卫生质量管理;2013年06期
4 薛嘉,徐嘉玲,郭庆荣,白良,杨成蓉,龙毅;卒中小组模式的卫生经济学评价[J];中国临床康复;2004年34期
5 何晶晶;朱传才;肖登峰;;口岸甲型H1N1流感防控措施的卫生经济学评价[J];口岸卫生控制;2013年03期
6 陈宁姗,金顺花,黄冬梅,张德春;磨合成本法在卫生经济学评价中的应用[J];国外医学(卫生经济分册);1998年04期
7 肖卫忠,谢汝萍,王觉生,罗祖明;脑卒中患者早期强化康复治疗的卫生经济学评价[J];中国临床康复;2003年03期
8 ;2004年《诊断学理论与实践》杂志函授继续医学教育——卫生经济学评价试题答案[J];诊断学理论与实践;2004年05期
9 吴育彬;彭佳鹏;吴伟;张庆英;;急性缺血性脑卒中静脉溶栓疗效与卫生经济学评价[J];中外医疗;2013年36期
10 周红;吴彦领;陈立新;;2004-2005年三门峡市结核病防治的卫生经济学评价[J];实用预防医学;2009年02期
相关会议论文 前2条
1 丁喜顺;付来文;李兵;丁秀贞;曹怀峰;;鄂尔多斯市实施结核病防治规划(2001-2010)卫生经济学评价[A];科技创新与经济结构调整——第七届内蒙古自治区自然科学学术年会优秀论文集[C];2012年
2 杨娟;魏文强;杨春霞;李融;肖慧娟;梁好;李新庆;乔友林;;食管癌筛查及早诊早治项目成本估计[A];中国第九届全国食管癌学术会议论文集[C];2009年
相关博士学位论文 前2条
1 辛倩倩;广州市艾滋病检测策略的卫生经济学评价[D];中国疾病预防控制中心;2013年
2 刘辉霞;因工烧伤不同治疗方案的卫生经济学评价[D];中南大学;2013年
相关硕士学位论文 前2条
1 易华云;应用Markov模型对良性前列腺增生症四种治疗方案的卫生经济学评价[D];中南大学;2007年
2 杨思嘉;宁波市新生儿乙型肝炎疫苗卫生经济学评价[D];宁波大学;2013年
,本文编号:1589523
本文链接:https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/1589523.html